Lunsumio intravenous drip 1mg (Mosunetuzumab), from Chugai Pharmaceutical (YJ code: 4291476A1028, standard: 1mg 1mL bottle), is a bispecific antibody. It treats relapsed or refractory follicular lymphoma by targeting CD20 on cancer cells and CD3 on T-cells, activating the immune system to destroy cancer cells.
Lunsumio intravenous drip 1mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →